Back
Relmada Therapeutics Stock Price Chart
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
34
RLMD
Relmada Therapeutics
Last Price:
3.43
Seasonality Move:
-1.84%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade- The current trend is moderately bearish and RLMD is experiencing slight selling pressure.
Relmada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.55 | Sell |
| 20-day SMA: | 3.51 | Sell |
| 50-day SMA: | 3.24 | Buy |
| 200-day SMA: | 3.85 | Sell |
| 8-day EMA: | 3.51 | Sell |
| 20-day EMA: | 3.49 | Sell |
| 50-day EMA: | 3.37 | Buy |
| 200-day EMA: | 3.61 | Sell |
Relmada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 48.8 | Sell |
| Chaikin Money Flow: | -55295 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.35 - 3.59) | Sell |
| Bollinger Bands (100): | (2.79 - 3.75) | Buy |
Relmada Therapeutics Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Relmada Therapeutics Stock
Is Relmada Therapeutics Stock a Buy?
- Relmada Therapeutics share price is 3.44 while RLMD 8-day simple moving average is 3.55, which is a Sell signal.
- The stock price of RLMD is 3.44 while Relmada Therapeutics 20-day SMA is 3.51, which makes it a Sell.
- Relmada Therapeutics 50-day simple moving average is 3.24 while RLMD share price is 3.44, making it a Buy technically.
- RLMD stock price is 3.44 and Relmada Therapeutics 200-day simple moving average is 3.85, creating a Sell signal.
RLMD Technical Analysis vs Fundamental Analysis
Sell
34
Relmada Therapeutics (RLMD)
is a Sell
Is Relmada Therapeutics a Buy or a Sell?
-
Relmada Therapeutics stock is rated a Sell
The current Relmada Therapeutics [RLMD] share price is $3.44. The Score for RLMD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Relmada Therapeutics Stock Info
Market Cap:
103.8M
Price in USD:
3.44
Share Volume:
113.39K
Relmada Therapeutics 52-Week Range
52-Week High:
7.22
52-Week Low:
1.88
Sell
34
Relmada Therapeutics (RLMD)
is a Sell
Relmada Therapeutics Share Price Forecast
-
What is the Relmada Therapeutics stock price today?
The Relmada Therapeutics stock price is 3.44 USD today. -
Will RLMD stock go up or go down?
Relmada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Relmada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Relmada Therapeutics is overvalued.
Is Relmada Therapeutics Stock a Buy?
- Relmada Therapeutics share price is 3.44 while RLMD 8-day exponential moving average is 3.51, which is a Sell signal.
- The stock price of RLMD is 3.44 while Relmada Therapeutics 20-day EMA is 3.49, which makes it a Sell.
- Relmada Therapeutics 50-day exponential moving average is 3.37 while RLMD share price is 3.44, making it a Buy technically.
- RLMD stock price is 3.44 and Relmada Therapeutics 200-day simple moving average is 3.61, creating a Sell signal.
Fundamental Analysis of Relmada Therapeutics
Is Relmada Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.11 per share.
Technical Analysis of Relmada Therapeutics
Should I short Relmada Therapeutics stock?
- RLMD Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Relmada Therapeutics is a Buy
- Relmada Therapeutics Relative Strength Index (RSI) is 48.8, which suggest Relmada Therapeutics is oversold
- The Bollinger Bands (25) for Relmada Therapeutics is (3.35 - 3.59), which suggest Relmada Therapeutics is a Buy
- The Bollinger Bands (100) for Relmada Therapeutics is (2.79 - 3.75), which suggest Relmada Therapeutics is a Buy
* Relmada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.